RECIP 1.0: A Roadmap for Clinical Implementation
Objective response evaluation in oncologic disease is a key endpoint of patient outcome. Response assessment has been performed using tumor measurements at the individual lesion level. For example, RECIST 1.1 defines progression on CT images on the basis of a change in lesion diameter or occurrence
Authors
- Andrei Gafita (ORCID: https://orcid.org/0000-0002-4865-9192)
- Jérémie Calais (ORCID: https://orcid.org/0000-0002-8839-4379)
- Wolfgang P. Fendler (ORCID: https://orcid.org/0000-0002-5106-3584)
- Matthias Eiber (ORCID: https://orcid.org/0000-0003-2130-644X)
- Loïc Djaileb (ORCID: https://orcid.org/0000-0003-2784-6367)
Institutions
- Johns Hopkins University (US)
- Inserm (FR)
- German Cancer Research Center (DE)
- Johns Hopkins Medicine (US)
- Centre Hospitalier Universitaire de Grenoble (FR)
- Technical University of Munich (DE)
- Université Grenoble Alpes (FR)
Publication Details
- Journal
- Journal of Nuclear Medicine
- Published
- 2025-03-27
- DOI
- https://doi.org/10.2967/jnumed.124.268730
- Primary Topic
- Lung Cancer Treatments and Mutations
- Type
- article
- Field-Weighted Citation Impact
- 0.00